Amgen

Open: 213.75 Close: 218.07 Change: 4.32

10 lessons that an AI found about Amgen after reading internet.

The game is changing. There is a new strategy to evaluate Amgen fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Amgen are: Amgen, price, FTC, new, stock, block, research, and the …

Concept Map

Semantic Network

Stock Summary

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's products include Enbrel, Prolia, Xgeva, Otezla, Aranesp, and Repatha..

Today's Summary

Federal Trade Commission (FTC) signaled it had enough amgen deal to block amgen mega pharma deals after it announced it would try to block it. FTC sues to block Amgens $27.8 billion acquisition of Horizon Therapeutics. Wall Street analysts say Amgen price is currently Undervalued.

Today's News

Amgen Inc. (AMGN) stock price, quote & news - stock analysis. Amgen - amgn - stock price today - zacks. ccx-559 by amgen for solid tumor: likelihood of approval. Buy the Report. U.S. Supreme Court rules against Amgen bid to revive cholesterol drug patents. FTC sues to block Amgens $27.8 billion acquisition of Horizon Therapeutics. Yahoo Finance Live anchors Julie Hyman and Brad Smith discuss the sharp decline of Horizon shares after a report surfaced that the FTC is planning to sue to block the sale. FTC complaint against Amgen and Horizon provides insights into the agencys thinking and may hold clues regarding anticipated new merger guidelines. Federal Trade Commission (FTC) signaled it had enough amgen deal to block amgen mega pharma deals after it announced it would try to block it. AbbVie shares were down more than 4%, while Amgen fell nearly 4%. Amgen (1amgn) stock price, quote, news & analysis - tipranks.com.com. Wall Street analysts say Amgen price is currently Undervalued. Amgen share price has underperformed the S&P500 Index by -16.33% over the past year. Amgens market cap is $114.49bn and the Amgen dividend yield is 3.71%. Amgen presents new research on otezla® (apremilast) in psoriatic arthritis at eular 2023. Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses. Amgen presents new research on otezla® (apremilast) in psoriatic arthritis at eular 2023. Amgen plans to take heart drug into phase 3 to challenge novartis. Amgen announces new research examining the use of Otezla (apremilast) in psoriatic arthritis. Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses. Amgen announced new research examining the use of Otezla (apremilast) in psoriatic arthritis. Phase 4 MOSAIC study and an exploratory analysis of cardiometabolic risk factors. Amgen (NASDAQ:AMGN) is moving into a highly uncertain period, characterized by high levels of competition from biosimilars (generic biologics) for many of its aging blockbusters. Federal Trade Commission (FTC) has been taking a more adversarial approach to mergers and acquisitions lately.

Stock Profile

"Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. It has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; Eli Lilly and Company; Datos Health; and Verastem, Inc. to evaluate VS-6766 in combination with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. It has an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis and other autoimmune diseases; and research and development collaboration with Neumora Therapeutics, Inc. and Plexium, Inc. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California."

Keywords

How much time have you spent trying to decide whether investing in Amgen? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Amgen are: Amgen, price, FTC, new, stock, block, research, and the most common words in the summary are: amgen, stock, market, news, price, new, job, . One of the sentences in the summary was: Federal Trade Commission (FTC) signaled it had enough amgen deal to block amgen mega pharma deals after it announced it would try to block it. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #amgen #stock #market #news #price #new #job.